Trevi Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €189.20M +166.7% -€15.76M -74.8% -8.3% +0.80 pp N/A N/A
    (estimated) €70.93M +2,032.3% -€62.55M -27.9% -88.2% +25 pp N/A N/A
    (estimated) €3.33M +∞% -€86.72M +41.9% -2,606.9% -26 pp N/A N/A
    (estimated) €0.00 +NaN% -€61.11M +40.4% N/A N/A N/A
    (estimated) €0.00 +NaN% -€43.52M +6.5% N/A N/A N/A
    €0.00 +NaN% -€40.87M +64.8% N/A -€32.60M +21.1% N/A
    €0.00 +NaN% -€24.79M -0.3% N/A -€26.93M +12.7% N/A
    €0.00 +NaN% -€24.87M -14.1% N/A -€23.90M -3.2% N/A
    €0.00 +NaN% -€28.95M +3.6% N/A -€24.69M -0.1% N/A
    €0.00 +NaN% -€27.94M +25.8% N/A -€24.71M +25.5% N/A
    €0.00 +NaN% -€22.22M +26.8% N/A -€19.69M +27.3% N/A
    €0.00 +NaN% -€17.52M +59.8% N/A -€15.47M +127.7% N/A
    €0.00 +NaN% -€10.97M +16.0% N/A -€6.79M -28.9% N/A
    €0.00 -€9.46M N/A -€9.55M N/A

    Notifications